Company intelligence / Profile preview

Meotec GmbH

Aachen, North Rhine-Westphalia, Germany

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Meotec GmbH supplies bioabsorbable magnesium alloy materials for orthopedic implants. Their materials are used in Bioretec's RemeOs™ trauma screw, which received marketing authorization in the EU and US during 2022. The implants are designed to be resorbed and naturally replaced by bone, eliminating the need for removal surgery.

Therapeutic areas: Rare DiseasesRheumatologyOther
Modalities: Bioabsorbable metal implants
Industry: Chemicals & Materials

Partnerships

Bioretec Ltd (raw material supply agreement for RemeOs™ products)

Beyond the preview

Go deeper on Meotec GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meotec GmbH.

Explore the full profile